Executive Director, Translational Research Institute for Space Health (TRISH)
As Executive Director for the Translational Research Institute for Space Health (TRISH), Dorit Donoviel, Ph.D., leads a $0.25B NASA-funded innovation R&D program that finds, funds, and facilitates disruptive human health and performance solutions for astronauts traveling in deep space. In her previous role as deputy chief scientist of the National Space Biomedical Research Institute (NSBRI), Dr. Donoviel led both domestic and international research programs that bridged academic, industry, and government resources to deliver fast and cost-effective tangible results. She is the recipient of multiple honors from NASA and a recipient of the NSBRI Pioneer Award. Dr. Donoviel authors scientific articles in academic journals as well as the popular press. She speaks about space health concerns and innovative approaches to investing in science and medicine at domestic and international conferences. Dr. Donoviel is Associate Professor in the Department of Pharmacology and Chemical Biology and the Center for Space Medicine at Baylor College of Medicine (BCM) where she lectures to and mentors graduate and medical students. Before joining BCM, she led metabolism drug discovery programs at Lexicon Pharmaceuticals for 8 years. She is an avid scuba diver and a collector of Star Trek memorabilia.